Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.89
-0.34 (-4.71%)
Aug 14, 2025, 11:32 AM - Market open
Aura Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 107.37 | 31.69 | 41.06 | 121.58 | 149.06 | 17.39 | Upgrade
|
| Short-Term Investments | 69.94 | 119.4 | 185.09 | 67.23 | - | - | Upgrade
|
| Cash & Short-Term Investments | 177.31 | 151.09 | 226.15 | 188.81 | 149.06 | 17.39 | Upgrade
|
| Cash Growth | -5.39% | -33.19% | 19.78% | 26.66% | 757.03% | -46.40% | Upgrade
|
| Prepaid Expenses | 6.65 | 1.7 | 1.82 | 2.17 | 2.73 | 0.05 | Upgrade
|
| Restricted Cash | - | - | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Other Current Assets | - | 7.83 | 3.81 | 5.7 | 1.88 | 0.99 | Upgrade
|
| Total Current Assets | 183.96 | 160.62 | 231.79 | 196.7 | 153.7 | 18.46 | Upgrade
|
| Property, Plant & Equipment | 19.49 | 20.59 | 22 | 26.04 | 6.2 | 3.57 | Upgrade
|
| Other Long-Term Assets | 0.95 | 1.29 | 1.28 | 1.19 | 0.13 | 0.08 | Upgrade
|
| Total Assets | 204.4 | 182.5 | 255.08 | 223.94 | 160.03 | 22.1 | Upgrade
|
| Accounts Payable | 1.29 | 2.3 | 1.79 | 2.92 | 2.4 | 0.61 | Upgrade
|
| Accrued Expenses | 10.37 | 8.84 | 6.95 | 4.25 | 3.83 | 1.77 | Upgrade
|
| Current Portion of Leases | 3.2 | 3.15 | 2.69 | 2.96 | 0.62 | - | Upgrade
|
| Other Current Liabilities | - | 0.62 | 0.94 | 0.33 | 0.51 | 0.28 | Upgrade
|
| Total Current Liabilities | 14.85 | 14.91 | 12.36 | 10.46 | 7.36 | 2.66 | Upgrade
|
| Long-Term Leases | 14.92 | 15.62 | 16.87 | 17.9 | 0.36 | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | - | 0.08 | Upgrade
|
| Total Liabilities | 29.77 | 30.53 | 29.23 | 28.35 | 7.72 | 2.74 | Upgrade
|
| Additional Paid-In Capital | 603.33 | 525.93 | 512.62 | 406.56 | 304.45 | 8.17 | Upgrade
|
| Retained Earnings | -428.73 | -374.23 | -287.31 | -210.9 | -152.14 | -116.89 | Upgrade
|
| Comprehensive Income & Other | 0.03 | 0.26 | 0.54 | -0.07 | - | - | Upgrade
|
| Total Common Equity | 174.63 | 151.97 | 225.85 | 195.58 | 152.32 | -108.71 | Upgrade
|
| Shareholders' Equity | 174.63 | 151.97 | 225.85 | 195.58 | 152.32 | 19.36 | Upgrade
|
| Total Liabilities & Equity | 204.4 | 182.5 | 255.08 | 223.94 | 160.03 | 22.1 | Upgrade
|
| Total Debt | 18.11 | 18.77 | 19.56 | 20.86 | 0.98 | - | Upgrade
|
| Net Cash (Debt) | 159.2 | 132.33 | 206.59 | 167.95 | 148.09 | 17.39 | Upgrade
|
| Net Cash Growth | -5.45% | -35.95% | 23.01% | 13.41% | 751.42% | -46.32% | Upgrade
|
| Net Cash Per Share | 3.06 | 2.67 | 5.21 | 5.61 | 28.70 | 47.37 | Upgrade
|
| Filing Date Shares Outstanding | 62.12 | 50.23 | 49.5 | 37.8 | 29.22 | 0.44 | Upgrade
|
| Total Common Shares Outstanding | 62.07 | 50 | 49.35 | 37.77 | 29.21 | 0.38 | Upgrade
|
| Working Capital | 169.11 | 145.71 | 219.44 | 186.25 | 146.35 | 15.79 | Upgrade
|
| Book Value Per Share | 2.81 | 3.04 | 4.58 | 5.18 | 5.21 | -285.22 | Upgrade
|
| Tangible Book Value | 174.63 | 151.97 | 225.85 | 195.58 | 152.32 | -108.71 | Upgrade
|
| Tangible Book Value Per Share | 2.81 | 3.04 | 4.58 | 5.18 | 5.21 | -285.22 | Upgrade
|
| Machinery | - | 8.46 | 7.8 | 7.43 | 5.64 | 4.77 | Upgrade
|
| Construction In Progress | - | 0.27 | 0.39 | 1.81 | 2.37 | 1.15 | Upgrade
|
| Leasehold Improvements | - | 0.47 | - | - | 0.01 | - | Upgrade
|
Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.